美股详情

本页面由Tiger Trade Technology Pte. Ltd.提供服务

Provectus生物制药

0.0617

-0.0001-0.10%

成交量：11.21万

成交额：6,919.11

市值：2,593.13万

市盈率：-4.65

高：0.0620

开：0.0618

低：0.0617

收：0.0618

52周最高：0.1050

52周最低：0.0380

股本：4.20亿

流通股本：3.87亿

量比：4.53

换手率：0.03%

股息：- -

股息率：- -

每股收益(TTM):-0.0133

每股收益(LYR):-0.0213

净资产收益率：22.69%

总资产收益率：-501.90%

市净率：-3.85

市盈率(LYR):-2.89

数据加载中...

总览公司新闻公告

公司资料

公司名字：

Provectus生物制药

交易所：

OTCQB

成立时间：

2002

员工人数：

6

公司地址：

800 South Gay Street,Suite 1610,Knoxville,Tennessee,United States

官网：

http://www.pvct.com

邮编：

37929

电话：

传真：

866 998 0005

简介：

Provectus Biopharmaceuticals, Inc.于2002年在特拉华成立，连同它的六个全资子公司和一个控股公司管理在一个综合的基础上，本文所指的是一个发展阶段的生物制药公司，主要从事发展民族医药肿瘤和皮肤病。公司的目标是开发出更安全，更有效的替代治疗，比传统的治疗方法，创伤小、更经济。公司开发并打算许可证或市场和销售的两种处方药的候选人，光伏- 10和PH - 10。

{"basename":"/hans","ssrTDKData":{"titleTemplate":"%s - 老虎证券","title":"老虎证券全球投资理财平台| 一站式投资美股新股港股A股","description":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","keywords":"老虎证券,老虎证券开户,老虎券商,老虎证券官网,老虎证券app,tigertrade老虎证券,股票,炒股,新加坡股票交易平台,投资,投资理财","social":{"ogDescription":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/hans/stock/PVCT/company"},"companyName":"老虎证券"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"PVCT","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"PVCT\",,,,,undefined,":{"symbol":"PVCT","market":"US","secType":"STK","nameCN":"Provectus生物制药","latestPrice":0.0617,"timestamp":1781710980000,"preClose":0.06176,"halted":0,"volume":112066,"delay":15,"changeRate":-0.0009715025906736479,"floatShares":386656900,"shares":420279879,"eps":-0.013279,"marketStatus":"交易中","change":-0.00006,"latestTime":"06-17 11:43:00 EDT 延时","open":0.06176,"high":0.062,"low":0.0617,"amount":6919.112180664,"amplitude":0.004858,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"otc":true,"ttmEps":-0.013279,"tradingStatus":2,"nextMarketStatus":{"tag":"盘后交易","tradingStatus":3,"beginTime":1781726400000},"marketStatusCode":2,"adr":0,"adrRate":0,"exchange":"OTCQB","adjPreClose":0.06176,"volumeRatio":4.529352},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"PVCT\",,,,,undefined,":{"symbol":"PVCT","floatShares":386656900,"roa":"-501.90%","roe":"22.69%","lyrEps":-0.021324,"volumeRatio":4.529352,"shares":420279879,"dividePrice":0,"high":0.062,"amplitude":0.004858,"preClose":0.06176,"low":0.0617,"week52Low":0.038,"pbRate":"-3.85","psRate":"451.14","week52High":0.105,"institutionHeld":0.0006,"latestPrice":0.0617,"eps":-0.013279,"divideRate":0,"volume":112066,"delay":15,"ttmEps":-0.013279,"open":0.06176,"prevYearClose":0.0559,"prevWeekClose":0.0606,"prevMonthClose":0.065,"prevQuarterClose":0.0509,"fiveDayClose":0.0686,"twentyDayClose":0.0661,"sixtyDayClose":0.0509},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/PVCT\",params:#limit:5,,,undefined,":[{"market":"US","date":"2024-11-12","symbol":"PVCT","fiscalQuarterEnding":null,"expectedEps":null,"name":null,"time":"","type":"earning","dateTimestamp":1731387600000,"reportTimeType":"","actualEps":null},{"market":"US","date":"2024-08-13","symbol":"PVCT","fiscalQuarterEnding":null,"expectedEps":null,"name":null,"time":"","type":"earning","dateTimestamp":1723521600000,"reportTimeType":"","actualEps":null},{"market":"US","date":"2024-05-14","symbol":"PVCT","fiscalQuarterEnding":null,"expectedEps":null,"name":null,"time":"","type":"earning","dateTimestamp":1715659200000,"reportTimeType":"","actualEps":null},{"market":"US","date":"2024-03-28","symbol":"PVCT","fiscalQuarterEnding":null,"expectedEps":null,"name":null,"time":"","type":"earning","dateTimestamp":1711598400000,"reportTimeType":"","actualEps":null},{"market":"US","date":"2024-02-22","symbol":"PVCT","fiscalQuarterEnding":null,"expectedEps":null,"name":null,"time":"","type":"earning","dateTimestamp":1708578000000,"reportTimeType":"","actualEps":null}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"PVCT\",market:\"US\",,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"PVCT\",market:\"US\",delay:false,,,undefined,":{},"@#url:\"stock.company.info\",,undefined,":{"stockCompanyProfile":{"companyId":2336891,"yearFounded":2002,"employeeNum":6,"address":"800 South Gay Street,Suite 1610,Knoxville,Tennessee,United States","zipCode":"37929","officePhone":"866 594 5999","officeFax":"866 998 0005","fiscalYearEnd":"12-31"},"stockCompanyDetail":{"websiteUrl":"http://www.pvct.com","stockEarnings":[{"period":"1week","weight":-0.0318},{"period":"1month","weight":-0.0603},{"period":"3month","weight":-0.1125},{"period":"6month","weight":0.1692},{"period":"1year","weight":-0.1469},{"period":"ytd","weight":0.278}],"description":"Provectus Biopharmaceuticals, Inc.于2002年在特拉华成立，连同它的六个全资子公司和一个控股公司管理在一个综合的基础上，本文所指的是一个发展阶段的生物制药公司，主要从事发展民族医药肿瘤和皮肤病。公司的目标是开发出更安全，更有效的替代治疗，比传统的治疗方法，创伤小、更经济。公司开发并打算许可证或市场和销售的两种处方药的候选人，光伏- 10和PH - 10。","exchange":"OTCQB","name":"Provectus生物制药","nameEN":"Provectus Biopharmaceuticals, Inc."}},"@#url:\"https://hq.skytigris.cn/fundamental/company/manager/list\",params:#symbol:\"PVCT\",market:\"US\",,,undefined,":null}}